Department of Angiology and Vascular Surgery, Complejo Asistencial de Salamanca, Salamanca, Spain.
Department of Internal Medicine, Complejo Hospitalario Universitario de Cartagena, Murcia, Spain.
J Vasc Surg. 2014 May;59(5):1362-7.e1. doi: 10.1016/j.jvs.2013.11.091. Epub 2014 Jan 16.
Some physicians are still concerned about the safety of treatment at home of patients with acute deep venous thrombosis (DVT).
We used data from the RIETE (Registro Informatizado de la Enfermedad TromboEmbólica) registry to compare the outcomes in consecutive outpatients with acute lower limb DVT according to initial treatment at home or in the hospital. A propensity score-matching analysis was carried out with a logistic regression model.
As of December 2012, 13,493 patients had been enrolled. Of these, 4456 (31%) were treated at home. Patients treated at home were more likely to be male and younger and to weigh more; they were less likely than those treated in the hospital to have chronic heart failure, lung disease, renal insufficiency, anemia, recent bleeding, immobilization, or cancer. During the first week of anticoagulation, 27 patients (0.20%) suffered pulmonary embolism (PE), 12 (0.09%) recurrent DVT, and 51 (0.38%) major bleeding; 80 (0.59%) died. When only patients treated at home were considered, 12 (0.27%) had PE, 4 (0.09%) had recurrent DVT, 6 (0.13%) bled, and 4 (0.09%) died (no fatal PE, 3 fatal bleeds). After propensity analysis, patients treated at home had a similar rate of venous thromboembolism recurrences and a lower rate of major bleeding (odds ratio, 0.4; 95% confidence interval, 0.1-1.0) or death (odds ratio, 0.2; 95% confidence interval, 0.1-0.7) within the first week compared with those treated in the hospital.
In outpatients with DVT, home treatment was associated with a better outcome than treatment in the hospital. These data may help safely treat more DVT patients at home.
一些医生仍然担心在家治疗急性深静脉血栓形成(DVT)患者的安全性。
我们使用 RIETE(血栓栓塞疾病信息化登记)登记处的数据,根据急性下肢 DVT 患者初始治疗是在家庭还是在医院,比较连续门诊患者的结局。采用逻辑回归模型进行倾向评分匹配分析。
截至 2012 年 12 月,共纳入 13493 例患者。其中 4456 例(31%)在家治疗。与在医院治疗的患者相比,在家治疗的患者更可能是男性和年轻,体重更重;与在医院治疗的患者相比,他们更不可能患有慢性心力衰竭、肺部疾病、肾功能不全、贫血、近期出血、固定、或癌症。在抗凝治疗的第一周内,27 例(0.20%)发生肺栓塞(PE),12 例(0.09%)发生复发性 DVT,51 例(0.38%)发生大出血;80 例(0.59%)死亡。当仅考虑在家治疗的患者时,12 例(0.27%)发生 PE,4 例(0.09%)发生复发性 DVT,6 例(0.13%)发生出血,4 例(0.09%)死亡(无致命性 PE,3 例致命性出血)。经倾向分析后,与在医院治疗的患者相比,在家治疗的患者静脉血栓栓塞复发率相似,大出血发生率较低(比值比,0.4;95%置信区间,0.1-1.0)或死亡率较低(比值比,0.2;95%置信区间,0.1-0.7)在第一周内。
在 DVT 门诊患者中,家庭治疗的结局优于医院治疗。这些数据可能有助于更安全地在家中治疗更多的 DVT 患者。